Brokerages Set MBX Biosciences, Inc. (NYSE:MBX) PT at $37.40
Shares of MBX Biosciences, Inc. (NYSE:MBX – Get Free Report) have received a consensus rating of “Buy” from the six ratings firms that are covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month target price among analysts that have issued ratings on […]
Shares of MBX Biosciences, Inc. (NYSE:MBX – Get Free Report) have received a consensus rating of “Buy” from the six ratings firms that are covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month target price among analysts that have issued ratings on […]
